Literature DB >> 6987785

Dissociation of natural killer cell activity and antibody-dependent cell-mediated cytotoxicity in kidney allograft recipients receiving high-dose immunosuppressive therapy.

M Lipinski, T Tursz, H Kreis, Y Finale, J L Amiel.   

Abstract

Peripheral blood lymphocytes (PBLs) of normal subjects and of kidney allograft recipients treated with immunosuppressive drugs (azathioprine and prednisone) were tested for natural killer (NK) cell activity against K562 cells, and for killer (K) cell activity against L-1210 cells in the presence of rabbit anti-L-1210 antiserum. It was found that the natural cell-mediated cytotoxicity (NCMC) was abolished in the immunosuppressed patients while the antibody-dependent cell-mediated cytotoxicity (ADCC) remained normal. Furthermore, no correlation was observed between both activities in the treated group, whereas a strong positive correlation did exist in the control population. Uremic routinely hemodialyzed patients tested for NK cell activity did not exhibit any significant difference with the control group. These data indicate that NCMC and ADCC are different functions, apparently correlated in normal population but discriminated by immunosuppressive medical treatment. The abrogation of NCMC in patients in whom the risk of malignancy is highly increased strengthens the concept of a crucial role of NK cells in the in vivo surveillance toward malignancies.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6987785     DOI: 10.1097/00007890-198003000-00010

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  13 in total

Review 1.  Immunosuppressive therapy for renal transplantation.

Authors:  C B Carpenter; T B Strom
Journal:  Springer Semin Immunopathol       Date:  1984

2.  Depressed spontaneous cellular cytotoxicity associated with normal or enhanced antibody-dependent cellular cytotoxicity in patients on chronic haemodialysis.

Authors:  A M Badger; D B Bernard; B A Idelson; S R Cooperband
Journal:  Clin Exp Immunol       Date:  1981-09       Impact factor: 4.330

3.  NK cell activity and skin test antigen stimulation of NK like CMC in vitro are decreased to different degrees in pregnancy and sarcoidosis.

Authors:  D Tartof; J J Curran; S L Yang; C Livingston
Journal:  Clin Exp Immunol       Date:  1984-08       Impact factor: 4.330

4.  Azathioprine suppression of natural killer activity and antibody-dependent cellular cytotoxicity in renal transplant recipients.

Authors:  H E Prince; R B Ettenger; F J Dorey; R N Fine; J L Fahey
Journal:  J Clin Immunol       Date:  1984-07       Impact factor: 8.317

5.  Natural killer-cell activity, interferon-alpha 2 production, and interleukin-2 production in cyclosporine-treated and conventionally immunosuppressed human allograft recipients.

Authors:  P J Guillou; G R Giles; C W Ramsden
Journal:  J Clin Immunol       Date:  1986-09       Impact factor: 8.317

6.  Spontaneous lymphocyte-mediated (NK cell) cytotoxicity in systemic sclerosis: a comparison with antibody-dependent lymphocyte (K cell) cytotoxicity.

Authors:  J K Wright; P Hughes; N R Rowell
Journal:  Ann Rheum Dis       Date:  1982-08       Impact factor: 19.103

7.  Extremely high levels of natural killer cells in angioimmunoblastic lymphadenopathy.

Authors:  F S Ligler; M Patel; D Strayer; I Brodsky; H Bonner; T J Linna
Journal:  J Clin Immunol       Date:  1983-10       Impact factor: 8.317

8.  Familial occurrence of breast cancer is associated with reduced natural killer cytotoxicity.

Authors:  D R Strayer; W A Carter; I Brodsky
Journal:  Breast Cancer Res Treat       Date:  1986       Impact factor: 4.872

9.  Natural and antibody-dependent cytotoxicity in different clinical stages of human immunodeficiency virus type 1 infection.

Authors:  K Ljunggren; A Karlson; E M Fenyö; M Jondal
Journal:  Clin Exp Immunol       Date:  1989-02       Impact factor: 4.330

10.  Immunological consequence of renal transplantation and immunosuppression. I. Alterations in human natural killer-cell activity.

Authors:  W C Waltzer; R J Bachvaroff; A Arnold; D Anaise; F T Rapaport
Journal:  J Clin Immunol       Date:  1985-03       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.